Dabigatran: A new oral anticoagulant. Guidelines to follow in oral surgery procedures. A systematic review of the literature

Dabigatran is a newly commercialized drug that is replacing other anticoagulants in the prevention of venous thromboembolism, stroke and systemic arterial valve embolism. It acts directly on thrombin presenting in a dynamic and predictable way, which does not require monitoring these patients. There...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Medicina oral, patología oral y cirugía bucal patología oral y cirugía bucal, 2016-11, Vol.21 (6), p.e679-e688
Hauptverfasser:	Muñoz-Corcuera, M, Ramírez-Martínez-Acitores, L, López-Pintor, R-M, Casañas-Gil, E, Hernández-Vallejo, G
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Anticoagulants - therapeutic use Dabigatran - therapeutic use Dentistry Humans Oral Surgical Procedures Postoperative Hemorrhage - prevention & control Review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!